Giới Thiệu

The authors also observed that the areas under GH peaks at night were significantly higher than those during the day for both young and elderly men, confirming that the majority of GH release occurs at night irrespective of age. Additionally, in elderly men, serum testosterone levels were positively correlated with 24-h mean GH levels although it should be noted that these improvements in testosterone were not statistically significant. In the elderly men, high-dose sermorelin treatment elevated mean 24-h GH, peak GH amplitude, and GH area under the peaks. One group was first treated with sermorelin followed by GHRH 1–40 with a one-week interval between treatments.
Other stacks introduce trade-offs such as off-target hormone activation or longer administration complexity. However, CJC-1295 NO DAC remains the most validated option because its half-life closely matches ipamorelin’s, allowing both peptides to peak simultaneously and produce maximum synergistic amplification. This stack has been studied in multiple clinical trials, produces no cortisol or prolactin elevation, and amplifies GH release 3–5 times higher than either peptide alone. Synergistic amplification occurs when you activate different receptor pathways simultaneously. The Tesamorelin Ipamorelin Growth Hormone Stack combines both peptides in pre-measured vials optimized for body composition protocols. A study published in The Lancet demonstrated that tesamorelin reduced visceral adipose tissue by 15.2% over 26 weeks in adults with abdominal obesity. Pair ipamorelin with tesamorelin, a GHRH analog specifically validated for visceral adipose reduction.
The main clinical application of these agents is the treatment of growth hormone deficiency. Although limited work has explored ipamorelin’s effects on hypogonadism specifically, the compound’s interactions with the GI tract are an important factor in determining body fat and overall composition. Nass et al. conducted a 2-year randomized, double-blind, placebo-controlled, modified-crossover trial evaluating ibutamoren’s effects on body composition (53). While the authors found that total body fat was unchanged as previously observed, the mean total body fat decreased by a non-significant 0.2 kg at 2 weeks and 0.4 kg at 8 weeks compared to baseline.
Although this approach limits our understanding of each individual compound, the increases in IGF-1 levels seen at 90, 180, and 270 days are a testament to the GHRP compounds’ efficacy. In the previously mentioned study by Sigalos et al., both GHRP-2 and GHRP-6 were administered with sermorelin as part of a combination GHS regimen (30). These conflicting results from the same investigators over the course of two separate studies underscore the fact that further work is required to understand the relationship between systemic factors and GHRP-2 treatment response.
Veldhuis et al. conducted a prospective, randomized double blind trial to further evaluate the effects of GHRH and GHRP-2 in 24 healthy young men with experimentally induced hypogonadism (42). These findings demonstrate that GHRP-2 is a potent stimulator of GH secretion in both eugonadal and hypogonadal men with a synergistic effect when co-administered with GHRH, from which sermorelin is derived. Moreover, GHS treatment decreased the time to maximal GH secretion with a median time reduction of 43%. A combined analysis found that the treatment with GHRP-2 led to a 47-fold increase in pulsatile GH secretion, while GHRH treatment itself only led to a 20-fold increase. Ten men were given 2 injections of depot leuprolide acetate 3 weeks apart to create a hypogonadal state. Veldhuis and colleagues evaluated the effects of GHRP on the waveform and timing of GH secretion in 12 eugonadal men and 10 men with experimentally induced hypogonadism (41).
This hub is catered for ambitious biohackers who want personal control over their body. The muscle-building benefit is real but indirect — it comes from the entire cascade of improved recovery, sleep, and metabolic function. MK-677 stimulates your body’s own GH production in pulsatile patterns, which more closely mimics natural physiology. For Natty Plus practitioners using GH secretagogues like MK-677 rather than exogenous GH, the effects are even more nuanced. These are indirect but powerful contributors to muscle growth. Ascension Peptides carries ipamorelin at 5mg per vial, with third-party purity verification.
Activation of these two receptors affects several downstream signaling pathways, culminating in a host of antifibrotic, anabolic, vasodilative, cardioprotective, and anti-inflammatory effects (34). The study’s results also emphasize the role of sermorelin as a potent GH and IGF-1 stimulator, which can yield significant increases in lean body mass. Despite these shortcomings, these findings highlight that sermorelin can lead to elevations in IGF-1 when used in conjunction with other GHS, showing the potential role of sermorelin in the treatment of hypogonadism. Additionally, the lack of comparator groups receiving GHS monotherapy and data regarding changes in body composition restrict the ability to fully understand the impact of the individual GHS.

Nữ